» Articles » PMID: 37375766

Live Cell Imaging by Förster Resonance Energy Transfer Fluorescence to Study Trafficking of PLGA Nanoparticles and the Release of a Loaded Peptide in Dendritic Cells

Overview
Publisher MDPI
Specialty Chemistry
Date 2023 Jun 28
PMID 37375766
Authors
Affiliations
Soon will be listed here.
Abstract

Our previous study demonstrated that a selected β-lactoglobulin-derived peptide (BLG-Pep) loaded in poly(lactic--glycolic acid) (PLGA) nanoparticles protected mice against cow's milk allergy development. However, the mechanism(s) responsible for the interaction of the peptide-loaded PLGA nanoparticles with dendritic cells (DCs) and their intracellular fate was/were elusive. Förster resonance energy transfer (FRET), a distance-dependent non-radioactive energy transfer process mediated from a donor to an acceptor fluorochrome, was used to investigate these processes. The ratio of the donor (Cyanine-3)-conjugated peptide and acceptor (Cyanine-5) labeled PLGA nanocarrier was fine-tuned for optimal (87%) FRET efficiency. The colloidal stability and FRET emission of prepared NPs were maintained upon 144 h incubation in PBS buffer and 6 h incubation in biorelevant simulated gastric fluid at 37 °C. A total of 73% of Pep-Cy3 NP was internalized by DCs as quantified using flow cytometry and confirmed using confocal fluorescence microscopy. By real-time monitoring of the change in the FRET signal of the internalized peptide-loaded nanoparticles, we observed prolonged retention (for 96 h) of the nanoparticles-encapsulated peptide as compared to 24 h retention of the free peptide in the DCs. The prolonged retention and intracellular antigen release of the BLG-Pep loaded in PLGA nanoparticles in murine DCs might facilitate antigen-specific tolerance induction.

Citing Articles

Recent Advances in Peptide-Loaded PLGA Nanocarriers for Drug Delivery and Regenerative Medicine.

Omidian H, Wilson R, Castejon A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861188 PMC: 11768227. DOI: 10.3390/ph18010127.

References
1.
Schulze M, Wucherpfennig K . The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway. Curr Opin Immunol. 2011; 24(1):105-11. PMC: 3288754. DOI: 10.1016/j.coi.2011.11.004. View

2.
Godkin A, Smith K, Willis A, Tejada-Simon M, Zhang J, Elliott T . Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions. J Immunol. 2001; 166(11):6720-7. DOI: 10.4049/jimmunol.166.11.6720. View

3.
Monkare J, Pontier M, van Kampen E, Du G, Leone M, Romeijn S . Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery. Eur J Pharm Biopharm. 2018; 129:111-121. DOI: 10.1016/j.ejpb.2018.05.031. View

4.
Liu Z, Roche P . Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells. Front Physiol. 2015; 6:1. PMC: 4311620. DOI: 10.3389/fphys.2015.00001. View

5.
Gu P, Wusiman A, Zhang Y, Liu Z, Bo R, Hu Y . Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses. Mol Pharm. 2019; 16(12):5000-5012. DOI: 10.1021/acs.molpharmaceut.9b00860. View